Cite
HARVARD Citation
Koller, M. et al. (2022). Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma – Interpretation guidance derived from two randomized EORTC trials. Lung cancer. pp. 65-72. [Online].